These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11850281)

  • 1. Novel use of a guanosine prodrug approach to convert 2',3'-didehydro-2',3'-dideoxyguanosine into a viable antiviral agent.
    Ray AS; Yang Z; Chu CK; Anderson KS
    Antimicrob Agents Chemother; 2002 Mar; 46(3):887-91. PubMed ID: 11850281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of anti-human immunodeficiency virus activity of beta-D-6-cyclopropylamino-2',3'-didehydro-2',3'-dideoxyguanosine.
    Ray AS; Hernandez-Santiago BI; Mathew JS; Murakami E; Bozeman C; Xie MY; Dutschman GE; Gullen E; Yang Z; Hurwitz S; Cheng YC; Chu CK; McClure H; Schinazi RF; Anderson KS
    Antimicrob Agents Chemother; 2005 May; 49(5):1994-2001. PubMed ID: 15855524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and anti-HIV activity of [d4U]-[trovirdine analogue] and [d4T]-[trovirdine analogue] heterodimers as inhibitors of HIV-1 reverse transcriptase.
    Gavriliu D; Fossey C; Ciurea A; Delbederi Z; Sugeac E; Ladurée D; Schmidt S; Laumond G; Aubertin AM
    Nucleosides Nucleotides Nucleic Acids; 2002; 21(8-9):505-33. PubMed ID: 12484448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and conformational analysis of novel 2',3'-didehydo-2',3'-dideoxy-4'-selenonucleosides.
    Ko YJ; Choi WJ; Jun JH; Zhao LX; Jeong LS
    Nucleic Acids Symp Ser (Oxf); 2008; (52):555-6. PubMed ID: 18776500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of prodrug-type anti-HIV agents conjugating a REVERSE transcriptase inhibitor to a HIV-1 integrase inhibitor by a spontaneously cleavable linker.
    Fossey C; Vu AH; Vidu A; Zarafu I; Laduree D; Schmidt S; Laumond G; Aubertin AM
    J Enzyme Inhib Med Chem; 2007 Oct; 22(5):591-607. PubMed ID: 18035828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, anti-human immunodeficiency virus activity and esterase lability of some novel carboxylic ester-modified phosphoramidate derivatives of stavudine (d4T).
    McGuigan C; Sutton PW; Cahard D; Turner K; O'Leary G; Wang Y; Gumbleton M; De Clercq E; Balzarini J
    Antivir Chem Chemother; 1998 Nov; 9(6):473-9. PubMed ID: 9865385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marked inhibitory activity of masked aryloxy aminoacyl phosphoramidate derivatives of dideoxynucleoside analogues against visna virus infection.
    Balzarini J; Cahard D; Wedgwood O; Salgado A; Velázquez S; Yarnold CJ; De Clercq E; McGuigan C; Thormar H
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr; 17(4):296-302. PubMed ID: 9525429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane Permeable, Bioreversibly Modified Prodrugs of Nucleoside Diphosphate-γ-Phosphonates.
    Jia X; Weber S; Schols D; Meier C
    J Med Chem; 2020 Oct; 63(20):11990-12007. PubMed ID: 32991174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, antiviral activity, and mechanism of drug resistance of D- and L-2',3'-didehydro-2',3'-dideoxy-2'-fluorocarbocyclic nucleosides.
    Wang J; Jin Y; Rapp KL; Bennett M; Schinazi RF; Chu CK
    J Med Chem; 2005 Jun; 48(11):3736-48. PubMed ID: 15916425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Complete conformational family of 2',3'-didehydro-2',3'-dideoxyguanosine: quantum chemical and electron density topological study].
    Ponomar'ova AG; Iurenko IeP; Zhurakovs'kyĭ RO; Govorun DM
    Ukr Biokhim Zh (1999); 2012; 84(1):67-78. PubMed ID: 22679760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and anti-HIV activity of 4'-modified carbocyclic nucleoside phosphonate reverse transcriptase inhibitors.
    Boojamra CG; Parrish JP; Sperandio D; Gao Y; Petrakovsky OV; Lee SK; Markevitch DY; Vela JE; Laflamme G; Chen JM; Ray AS; Barron AC; Sparacino ML; Desai MC; Kim CU; Cihlar T; Mackman RL
    Bioorg Med Chem; 2009 Feb; 17(4):1739-46. PubMed ID: 19179082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prodrugs of γ-Alkyl-Modified Nucleoside Triphosphates: Improved Inhibition of HIV Reverse Transcriptase.
    Zhao C; Weber S; Schols D; Balzarini J; Meier C
    Angew Chem Int Ed Engl; 2020 Dec; 59(49):22063-22071. PubMed ID: 32379948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 5-alkynylated d4T analogues as potential HIV-1 reverse transcriptase inhibitors.
    Ciurea A; Fossey C; Gavriliu D; Delbederi Z; Sugeac E; Laduree D; Schmidt S; Laumond G; Aubertin AM
    J Enzyme Inhib Med Chem; 2004 Dec; 19(6):511-9. PubMed ID: 15662955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. l-2',3'-Didehydro-2',3'-dideoxy-3'-fluoronucleosides: synthesis, anti-HIV activity, chemical and enzymatic stability, and mechanism of resistance.
    Chong Y; Gumina G; Mathew JS; Schinazi RF; Chu CK
    J Med Chem; 2003 Jul; 46(15):3245-56. PubMed ID: 12852755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of potential dual-target prodrugs of HIV-1 reverse transcriptase and nucleocapsid protein 7.
    Sun S; Huang B; Li Z; Wang Z; Sun L; Gao P; Kang D; Chen CH; Lee KH; Daelemans D; De Clercq E; Pannecouque C; Zhan P; Liu X
    Bioorg Med Chem Lett; 2020 Aug; 30(16):127287. PubMed ID: 32631509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D- and L-2',3'-didehydro-2',3'-dideoxy-3'-fluoro-carbocyclic nucleosides: synthesis, anti-HIV activity and mechanism of resistance.
    Wang J; Jin Y; Rapp KL; Schinazi RF; Chu CK
    J Med Chem; 2007 Apr; 50(8):1828-39. PubMed ID: 17373782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of an apionucleoside family and discovery of a prodrug with anti-HIV activity.
    Toti KS; Derudas M; Pertusati F; Sinnaeve D; Van den Broeck F; Margamuljana L; Martins JC; Herdewijn P; Balzarini J; McGuigan C; Van Calenbergh S
    J Org Chem; 2014 Jun; 79(11):5097-112. PubMed ID: 24804575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into the molecular mechanism of inhibition and drug resistance for HIV-1 RT with carbovir triphosphate.
    Ray AS; Yang Z; Shi J; Hobbs A; Schinazi RF; Chu CK; Anderson KS
    Biochemistry; 2002 Apr; 41(16):5150-62. PubMed ID: 11955063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies in the design of prodrugs of anti-HIV agents.
    Calogeropoulou T; Detsi A; Lekkas E; Koufaki M
    Curr Top Med Chem; 2003; 3(13):1467-95. PubMed ID: 14529522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of novel acetamide-substituted doravirine and its prodrugs as potent HIV-1 NNRTIs.
    Wang Z; Yu Z; Kang D; Zhang J; Tian Y; Daelemans D; De Clercq E; Pannecouque C; Zhan P; Liu X
    Bioorg Med Chem; 2019 Feb; 27(3):447-456. PubMed ID: 30606670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.